Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 May;4(10):205.
doi: 10.21037/atm.2016.03.53.

Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be premature

Ivo G Schoots  1
Affiliations
Comment

Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be premature

Ivo G Schoots. Ann Transl Med. 2016 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Reanalysis of data from Arsov et al. (3). Data is divided into the detection of high-grade (Gleason score ≥3+4) prostate cancer, low-grade (Gleason score 3+3) prostate cancer, and no prostate cancer, and the data for MRI-FUS-GB+TRUS-GB has been subdivided to show the results of MRI-FUS-GB and TRUS-GB separately. Con- and discordance of MRI-FUS-GB and TRUS-GB separately is assessed in the table in the lower right. Light green, light orange and light red shading indicate concordance between MRI-FUS-GB and TRUS-GB. Dark orange and dark red shading indicate discordance. TRUS-GB, transrectal ultrasound-guided biopsy; MRI-FUS-GB, MRI fused with ultrasound-guided biopsy; MRI-IB-GB, MRI in-bore guided biopsy; PCa, prostate cancer.
See this image and copyright information in PMC

Comment on

References

    1. Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015;313:390-7. 10.1001/jama.2014.17942 - DOI - PMC - PubMed
    1. Schoots IG, Roobol MJ, Nieboer D, et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 2015;68:438-50. 10.1016/j.eururo.2014.11.037 - DOI - PubMed
    1. Arsov C, Rabenalt R, Blondin D, et al. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 2015;68:713-20. 10.1016/j.eururo.2015.06.008 - DOI - PubMed
    1. Vourganti S, Rastinehad A, Yerram NK, et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012;188:2152-7. 10.1016/j.juro.2012.08.025 - DOI - PMC - PubMed
    1. Durmus T, Stephan C, Grigoryev M, et al. Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography. Rofo 2013;185:428-33. - PubMed

LinkOut - more resources